Koninklijke Philips N.V. (AMS:PHIA)
Netherlands
· Delayed Price · Currency is EUR 22.85
-0.30 (-1.30%)
Apr 29, 2026, 9:45 AM CET
Koninklijke Philips Revenue
In the year 2025, Koninklijke Philips had annual revenue of 17.83B EUR, down -1.04%. Koninklijke Philips had revenue of 5.10B in the quarter ending December 31, 2025, with 1.07% growth.
Revenue
17.83B
Revenue Growth
-1.04%
P/S Ratio
1.23
Revenue / Employee
291.95K
Employees
61,085
Market Cap
22.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.83B | -187.00M | -1.04% |
| Dec 31, 2024 | 18.02B | -148.00M | -0.81% |
| Dec 31, 2023 | 18.17B | 342.00M | 1.92% |
| Dec 31, 2022 | 17.83B | 671.00M | 3.91% |
| Dec 31, 2021 | 17.16B | -157.00M | -0.91% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BE Semiconductor Industries | 632.07M |
| CSG N.V. | 6.74B |
| NN Group | 14.34B |
| Koninklijke KPN | 5.80B |
| Heineken Holding | 28.75B |
| DSM-Firmenich AG | 9.03B |
| Adyen | 2.38B |
| HAL Trust | 13.25B |
Koninklijke Philips News
- 5 days ago - PHG Makes Notable Cross Below Critical Moving Average - Nasdaq
- 5 days ago - Royal Philips: Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction - Finanz Nachrichten
- 5 days ago - Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction - GlobeNewsWire
- 6 days ago - Philips (PHG) Secures FDA Clearance for Rembra Scanning Systems - GuruFocus
- 6 days ago - Royal Philips: Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - Finanz Nachrichten
- 6 days ago - Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - GlobeNewsWire
- 11 days ago - Koninklijke Philips NV (PHG) Shares Surge 3.7% -- What GF Score of 79 Tells Investors - GuruFocus
- 11 days ago - Weekly Buzz: FDA Okays TVTX, PHG; Rejects REPL; AIP Snaps Up AVNS; PDS, HOTH, SYRE, Paces Trials - Finanz Nachrichten